Adiposity in childhood is related to c-reactive protein and adiponectin in young adulthood: From the bogalusa heart study

Obesity

Volumn 19, Issue 1, 2011, Pages 185-190

  Toprak, Demet ^a   Toprak, Ahmet ^a   Chen, Wei ^a   Xu, Ji Hua ^a   Srinivasan, Sathanur ^a   Berenson, Gerald S ^a  

^a Tulane Center for Cardiovascular Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN, HUMAN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE; ARTICLE; BLOOD; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; ETHNOLOGY; FEMALE; HUMAN; LABORATORY TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLISM; OBESITY; PHYSIOLOGY; PRESCHOOL CHILD; SCHOOL CHILD; SKINFOLD THICKNESS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

ADIPONECTIN; ADIPOSITY; ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE FACTORS; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LONGITUDINAL STUDIES; LOUISIANA; MALE; OBESITY; YOUNG ADULT;

EID: 78650676728     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.75     Document Type: Article

References (43)

1. Berenson GS. Bogalusa Heart Study: a long-term community study of a rural biracial (black/white) population. Am J Med Sci 2001;322:267-274.
2. Berenson GS. Childhood risk factors predict adult risk associated with subclinical cardiovascular disease. The Bogalusa Heart Study. Am J Cardiol 2002;90:3L-7L.
3. Pasceri V, Willerson J T, Yeh E T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-2168.
4. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-126.
5. Juonala M, Viikari JS, Rönnemaa T et al. Childhood C-reactive protein in predicting CRP and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 2006;26:1883-1888.
6. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29-33.
7. Berenson GS, McMahan CA, Voors AV et al. Cardiovascular Risk Factors in Children-The Early Natural History of Atherosclerosis and Essential Hypertension. Oxford University Press: New York, 1980.
8. Berenson GS ed. Causation of Cardiovascular Risk Factors in Children: Perspectives on Cardiovascular Risk in Early Life. Raven: New York 1986.
9. Kuczmarski RJ, Ogden CL, Guo SS et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002;(246):1-190.
10. Tanner JM. The assessment of growth and development in children. Arch Dis Child 1952;27:10-33.
11. Srinivasan SR, Berenson GS. Serum lipoproteins in children and methods for study. In: Lewis L (ed). Handbook of Electrophoresis. CRC: Boca Raton, FL, 1983, pp 185-204.
12. Shah PK. Circulating markers of inflammation for vascular risk prediction: are they ready for prime time. Circulation 2000;101:1758-1759.
13. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843. (Pubitemid 30165206)
14. Torzewski J, Torzewski M, Bowyer DE et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998;18:1386-1392.
15. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74-80.
16. Hotamisligil GS, Arner P, Caro J F, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95:2409-2415.
17. Tuck CH, Holleran S, Berglund L. Hormonal regulation of lipoprotein(a) levels: effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women. Arterioscler Thromb Vasc Biol 1997;17:1822-1829.
18. Festa A, D'Agostino R Jr, Williams K et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001;25:1407-1415.
19. Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001;25:1327-1331.
20. Patel DA, Srinivasan SR, Xu JH et al. Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (black-white) younger adults: the Bogalusa Heart Study. Metab Clin Exp 2006;55:699-705.
21. Pitsavos C, Panagiotakos DB, Tzima N et al. Diet, exercise, and C-reactive protein levels in people with abdominal obesity: the ATTICA epidemiological study. Angiology 2007;58:225-233.
22. Engström G, Hedblad B, Stavenow L et al. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003; 52:2097-2101.
23. Saltevo J, Vanhala M, Kautiainen H, Laakso M. Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with the relative change in body mass index between childhood and adulthood. Diab Vasc Dis Res 2007;4:328-331.
24. Dreon DM, Slavin JL, Phinney SD. Oral contraceptive use and increased plasma concentration of C-reactive protein. Life Sci 2003; 73:1245-1252.
25. Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 1999;100:713-716. (Pubitemid 29383640)
26. Heilbronn LK, Noakes M, Clifton PM. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 2001;21:968-970.
27. Geffken D F, Cushman M, Burke GL et al. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 2001;153:242-250.
28. Pischon T, Girman CJ, Hotamisligil GS et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291:1730-1737.
29. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935.
30. Hulthe J, Hultén LM, Fagerberg B. Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Metabolism 2003;52:1612-1614.
31. Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 2006;55:1551-1557.
32. Ong KK, Frystyk J, Flyvbjerg A et al. Sex-discordant associations with adiponectin levels and lipid profiles in children. Diabetes 2006; 55:1337-1341.
33. Araneta MR, Barrett-Connor E. Adiponectin and ghrelin levels and body size in normoglycemic Filipino, African-American, and white women. Obesity (Silver Spring) 2007;15:2454-2462.
34. Devaraj S, Torok N, Dasu MR, Samols D, Jialal I. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol 2008;28:1368-1374.
35. Tsioufis C, Dimitriadis K, Selima M et al. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. Eur Heart J 2007;28:1162-1169.
36. Freedman DS, Khan LK, Serdula MK et al. The relation of childhood BMI to adult adiposity: the Bogalusa Heart Study. Pediatrics 2005;115:22-27.
37. Freedman DS, Wang J, Maynard LM et al. Relation of BMI to fat and fat-free mass among children and adolescents. Int J Obes (Lond) 2005;29:1-8.
38. Schutz Y, Kyle UU, Pichard C. Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98 y. Int J Obes Relat Metab Disord 2002;26:953-960.
39. Wells JC, Fewtrell MS. Measuring body composition. Arch Dis Child 2006;91:612-617.
40. Goran MI. Measurement issues related to studies of childhood obesity: assessment of body composition, body fat distribution, physical activity, and food intake. Pediatrics 1998;101:505-518.
41. Goran MI, Driscoll P, Johnson R, Nagy TR, Hunter G. Cross-calibration of body-composition techniques against dual-energy X-ray absorptiometry in young children. Am J Clin Nutr 1996;63:299-305.
42. Reilly JJ, Methven E, McDowell ZC et al. Health consequences of obesity. Arch Dis Child 2003;88:748-752.
43. Wright CM, Parker L, Lamont D, Craft AW. Implications of childhood obesity for adult health: findings from thousand families cohort study. BMJ 2001;323:1280-1284.